Are you worried about your liver health? HRI has dedicated technicians that pre-screen and identify potential Non-Alcoholic Steatohepatis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD). NASH and NAFLD have emerged as the most common chronic liver diseases worldwide, affecting up to 30% of adults in developed countries. Our goal is to educate the community of their potential risks. The non-invasive FibroScan® assessment is simple, painless, fast and free (now through the end of the year)!

Interested in an Open Study? Please fill the form out below!

Please select which Open Study you are interested in:*

By submitting this form you are giving consent for HRI to contact you regarding clinical research only. HRI does not sell or give away personal information to third parties.

This field is for validation purposes and should be left unchanged.
See If You Qualify

Contact Us Now